Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ebtesam Al-Najjar"'
Autor:
Doaa Bugazia, Ebtesam Al-Najjar, Abdullah Esmail, Saifudeen Abdelrahim, Karen Abboud, Adham Abdelrahim, Godsfavour Umoru, Hashem A. Rayyan, Ala Abudayyeh, Ala-Eddin Al Moustafa, Maen Abdelrahim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of death in the United States and is expected to be ranked second in the next 10 years due to poor prognosis and a rising incidence. Distant metastatic PDAC is associated w
Externí odkaz:
https://doaj.org/article/990ff639082a4c7da9c59ef7190486d5
Autor:
Batool Wael Alnahar, Bushray Almiqlash, Hala Hassanain, Ebtesam Al-Najjar, Abdullah Esmail, Asma Zainab, Iqbal Ratnani
Publikováno v:
Medicina, Vol 60, Iss 9, p 1495 (2024)
Paragangliomas are rare extra-adrenal neuroendocrine tumors originating from chromaffin tissue that present a diagnostic and therapeutic challenge due to their diverse clinical manifestations and low incidence. While these tumors often manifest as ca
Externí odkaz:
https://doaj.org/article/0ef120a59d0b4305882bb0314947e43a
Autor:
Abdullah Esmail, Mohamed Badheeb, Batool Wael Alnahar, Bushray Almiqlash, Yara Sakr, Ebtesam Al-Najjar, Ali Awas, Mohammad Alsayed, Bayan Khasawneh, Mohammed Alkhulaifawi, Amneh Alsaleh, Ala Abudayyeh, Yaser Rayyan, Maen Abdelrahim
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 910 (2024)
Cholangiocarcinoma (CCA) is a hepatic malignancy that has a rapidly increasing incidence. CCA is anatomically classified into intrahepatic (iCCA) and extrahepatic (eCCA), which is further divided into perihilar (pCCA) and distal (dCCA) subtypes, with
Externí odkaz:
https://doaj.org/article/5c120aa62630452bb6a4e46d09f220aa
Autor:
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8693-8719 (2022)
Pancreatic cancer (PC) is a highly malignant and aggressive tumor. Despite medical advancement, the silent nature of PC results in only 20% of all cases considered resectable at the time of diagnosis. It is projected to become the second leading caus
Externí odkaz:
https://doaj.org/article/4f41f71f303347289e258d46b054e3b4
Autor:
Maen Abdelrahim, Abdullah Esmail, Noor Al Saadi, Eva Zsigmond, Ebtesam Al Najjar, Doaa Bugazia, Hadeel Al-Rawi, Ayat Alsaadi, Ahmed O. Kaseb
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The COVID-19 pandemic has impacted every country in the world. With more than 400 million cases and more than 5.5 million deaths. The FDA either approved or authorized the emergency use for three vaccines against COVID-19. The treatment options of CO
Externí odkaz:
https://doaj.org/article/47b946686a72463d82f4fdc40722f132
Autor:
Maen Abdelrahim, Hadeel Al-Rawi, Abdullah Esmail, Jiaqiong Xu, Godsfavour Umoru, Fahad Ibnshamsah, Ala Abudayyeh, David Victor, Ashish Saharia, Robert McMillan, Ebtesam Al Najjar, Doaa Bugazia, Maryam Al-Rawi, Rafik M. Ghobrial
Publikováno v:
Current Oncology. 29:3585-3594
Background: The management of cholangiocarcinoma is continually reviewed on a current evidence basis to develop practice guidelines and consensus statements. However, the standardized treatment guidelines are still unclear for cholangiocarcinoma pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4531a2da8a201ec09989e8402bea9334
https://doi.org/10.3390/curroncol29050290
https://doi.org/10.3390/curroncol29050290